Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection

References

• Vaheri A, Henttonen H, Voutilainen L, Mustonen J, Sironen T, Vapalahti O. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–9.
   PubMed Web of Science ®Google Scholar
• Hautala T, Mähonen SM, Sironen T, Hautala N, Pääkkö E, Karttunen A, et al. Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Ann Med. 2010;42: 344–51.
   PubMed Web of Science ®Google Scholar
• Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev. 2003;24:341–56.
   PubMed Web of Science ®Google Scholar
• Richards AM. Natriuretic peptides: update on peptide release, bioactivity, and clinical use. Hypertension. 2007;50:25–30.
   Google Scholar
• Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. Biology of the natriuretic peptides. Am J Cardiol. 2008;101:3–8.
   PubMed Web of Science ®Google Scholar
• Troughton RW, Lewis LK, Yandle TG, Pemberton CJ, Nicholls MG. B-type natriuretic peptides: looking to the future. Ann Med. 2011;43: 188–97.
   Web of Science ®Google Scholar
• Vaheri A, Vapalahti O, Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol. 2008;18:277–88.
   PubMed Web of Science ®Google Scholar
• Hautala N, Kauma H, Vapalahti O, Mähonen SM, Vainio O, Vaheri A, et al. Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients. Brit J Ophthalmol. 2011;95:559–62.
   Google Scholar
• Ala-Kopsala M, Ruskoaho H, Leppäluoto J, Seres L, Skoumal R, Toth M, et al. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides. Clin Chem. 2005;51:708–18.
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Kokkonen L, Ala-Houhala I, Groundström K, Harmoinen A, Huhtala H, et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis. 2009;41:57–62.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994;26:7–13.
   PubMed Web of Science ®Google Scholar
• Connolly-Andersen AM, Ahlm K, Ahlm C, Klingström J. Puumala virus infections associated with cardiovascular causes of death. Emerg Infect Dis. 2013;19:126–8.
   Google Scholar
• Gutierrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, et al. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem. 2008;54:1339–48.
   Google Scholar
• Perman SM, Chang AM, Hollander JE, Gaieski DF, Trzeciak S, Birkhahn R, et al. Relationship between B-type natriuretic peptide and adverse outcome in patients with clinical evidence of sepsis presenting to the emergency department. Acad Emerg Med. 2011;18:219–22.
   Google Scholar
• Jeong EG, Nam HS, Lee SM, An WS, Kim SE, Son YK. Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Ren Fail. 2013;35:1216–22.
   PubMed Web of Science ®Google Scholar
• Ogawa T, de Bold AJ. Brain natriuretic Peptide production and secretion in inflammation. J Transplant. 2012;2012:962347.
   Google Scholar
• Glezeva N, Collier P, Voon V, Ledwidge M, McDonald K, Watson C, et al. Attenuation of monocyte chemotaxis—a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide. J Cardiovasc Transl Res. 2013;6:545–7.
   Google Scholar
• Hautala N, Kauma H, Rajaniemi SM, Sironen T, Vapalahti O, Pääkko E, et al. Signs of general inflammation and kidney function are associated with the ocular features of acute Puumala hantavirus infection. Scand J Infect Dis. 2012;44:956–62.
   PubMed Web of Science ®Google Scholar
• Nongpiur ME, Wong TY, Sabanayagam C, Lim SC, Tai ES, Aung T. Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study. Ophthalmology. 2010;117:477–83.
   PubMed Web of Science ®Google Scholar
• Harju M, Kivelä T, Lindbohm N, Koivusalo R, Paloheimo M. Intravenous hypertonic saline to reduce intraocular pressure. Acta Ophthalmol. 2013;91:625–9.
   Google Scholar